Dionisia Quiroga

8PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 04, 2026
Denosumab as Second-Line Treatment in Patients With Metastatic Breast Cancer: A Retrospective Descriptive Pilot Study From a Single Institution.

|Apr 16, 2026
Acute circulating tumor DNA dynamics during and after systemic therapy initiation for advanced triple-negative breast cancer.

|Jun 12, 2025
Impact of low hormone receptor expression on neoadjuvant chemotherapy response and patterns of care in non-metastatic HER2-negative breast cancer: a US National Cancer Database analysis.

Dionisia Quiroga, Charles Pei, Julie A Stephens

|Jun 19, 2024
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer.

Kai C C Johnson, Ai Ni, Dionisia Quiroga

|Jun 19, 2024
Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer.

Jasmine S Sukumar, Sagar Sardesai, Andy Ni

|May 27, 2024
An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer.

Dionisia Quiroga, Robert Wesolowski, Sara Zelinskas

Pageof 2

Frequent Collaborators

3 joint publications

Robert Wesolowski

2 joint publications

Daniel G Stover

1 joint publications

Logan Good

1 joint publications

Mahmoud Kassem